Keywords: USA, Helath care reform, Biosimilars, PhRMA, Massachusetts election

US drug industry group PhRMA warns it could pull out of health care bill support on biosimilars issue

Article | 18 January 2010

The debate on US health care reform, and in particular the exclusivity of patent protection for biosimilars, or follow-on biological ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in